$1.90
-0.02-1.04%
At close: Aug 13, 5:00 PM EST
$1.92
0.021.05%
After Hours: 9:14 AM EST
Chemomab Therapeutics Ltd
CMMBNASDAQ
Chemomab Therapeutics Earnings & Forecasts
Chemomab Therapeutics (CMMB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Chemomab Therapeutics Guidance
Recent Earnings Results
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.08 | $-0.10 | $-0.10 | $-0.36 |
| Actual | $-0.24 | $-0.24 | $-0.28 | $-0.36 |
| Surprise | -200.0% | -140.0% | -180.0% | 0.00% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q2 '26E | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.08 | $-0.04 | $-0.20 | $-0.20 |
| Revenue | ||||
| Consensus | — | — | — | — |
